Firefly Luciferase mRNA

Overview

Firefly Luciferase mRNA is a research-use reagent supporting mRNA r&d reagents workflows. with the Cap 0 structure, the mRNA with the Cap 1 structure is more suitable for the mammalian system and has a higher transcription efficiency. Written for clarity and traceability, the description stays close to the supplied product information so your ordering and documentation remain consistent.

Key Benefits

• Time-saving: Eliminates time-consuming mRNA preparation—ready for immediate transfection or LNP formulation.
• High capping efficiency: Features Cap 1 structure, optimized for enhanced compatibility in mammalian systems.
• Incorporation of modified nucleotides and poly (A) tail: Mitigates RNA-induced innate immune activation and improves mRNA stability. High transfection efficiency &.
• with the Cap 0 structure, the mRNA with the Cap 1 structure is more suitable for the mammalian system and has a higher transcription efficiency.
• Modified UTP and addition of poly (A) tails provide higher transcriptional efficiency and inhibit RNA-mediated innate immune activation while enhancing mRNA stability and longevity in vitro.

How it supports your workflow

When you’re standardizing experiments across people, sites, or timepoints, consistent reagents and consistent documentation matter just as much as speed. For mRNA r&d reagents workflows, the goal is often to keep the scientific rationale and the purchasing record aligned. Originally extracted from Firefly Photinus pyralis, Firefly Luciferase is commonly used as a bioluminescent reporter gene for gene regulation and function studies, suitable for experiments such as mRNA delivery, translation efficiency, cell viability, and in vivo imaging. with the Cap 0 structure, the mRNA with the Cap 1 structure is more suitable for the mammalian system and has a higher transcription efficiency. Modified UTP and addition of poly (A) tails provide higher transcriptional efficiency and inhibit RNA-mediated innate immune activation while enhancing mRNA stability and longevity in vitro and in vivo. The supplied feature set highlights time-saving and high capping efficiency, which can help teams standardize language and expectations across similar products. Because projects evolve, we aim for descriptions that remain searchable, specific, and easy to compare across catalog numbers—so you can reorder confidently and keep documentation consistent.

Applications & compatibility

This section summarizes where the product fits based on the supplied description and features. Originally extracted from Firefly Photinus pyralis, Firefly Luciferase is commonly used as a bioluminescent reporter gene for gene regulation and function studies, suitable for experiments such as mRNA delivery, translation efficiency, cell viability, and in. with the Cap 0 structure, the mRNA with the Cap 1 structure is more suitable for the mammalian system and has a higher transcription efficiency. If you’re matching this item to an established SOP, use the product name, catalog number, and the supplied features as the primary reference points.

Ideal for: groups that rely on mRNA r&d reagents workflows and want a product listing that is specific, easy to reference, and careful about scope without introducing unsupported claims. Ideal when you need a quick, confident match between what’s on the page and what’s in your records.